Supporting HIV-Affected Couples Trying to Conceive

A pilot study identifies a safe, effective strategy to help women with HIV have children in low-resource countries.

7:00 AM

Author | Beata Mostafavi

Women with HIV were once advised against having children for fear that the infection could be passed on to their babies.

But medical advancements are not only allowing people with HIV to live longer and fuller lives — but to grow their families, too.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

Timed vaginal insemination is a safe, effective way to help HIV-affected couples conceive, finds a new pilot study in Kenya led by a Michigan Medicine researcher and published in the Public Library of Science ONE.

Among 23 couples, in which the woman was HIV-positive and the man was not, timed vaginal insemination led to six live births without a case of HIV transmission.

SEE ALSO: Bringing Faith and Science Together to Fight HIV in Africa

"People who are living with a stable HIV infection are focused on fully integrating into their communities and living productive lives," says lead author Okeoma Mmeje, M.D., assistant professor of obstetrics and gynecology at Michigan Medicine. Mmeje conducted the study while at the University of California, San Francisco.

"HIV does not change an individual's desire to have children," she says. "Our study describes a feasible, safe and effective method for women living with HIV to achieve pregnancy."

HIV-serodiscordant

In sub-Saharan Africa, women disproportionately represent the majority of new HIV infections. An estimated 44 percent of couples in Kenya are HIV-serodiscordant, in which one partner is infected by HIV and the other is not. But about 20 to 50 percent of HIV-infected people still want to have children, according to previous research.

Current guidelines recommend antiretroviral treatment in HIV-serodiscordant couples — the therapy helps keep HIV at low levels, keeping people healthy for longer and reducing the risk of spreading HIV to others.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

But the effectiveness of antiretroviral therapy may not be routinely assessed or guaranteed with an undetectable HIV viral load, authors say.

"We know there's a strong desire among many HIV-affected couples to have children but that current strategies to suppress the virus may be inadequate," says Mmeje, who is also a member of the U-M Institute for Healthcare Policy and Innovation.

"More options to support safely becoming pregnant should be offered to these couples and integrated into HIV prevention programs," she says.

A fertility evaluation

Mmeje says health care providers caring for HIV-serodiscordant couples should also consider offering them a fertility evaluation before attempting to conceive or after several unsuccessful attempts.

SEE ALSO: Structural Cells Help Spread HIV Within Lymphoid Organs

Study participants were recruited from eight HIV care and treatment clinics in the Kisumu area of Western Kenya and included women ages 18 to 34. Instructional aids were used for the procedures, education and counseling sessions.

Couples were observed for two months before timed vaginal insemination and were tested and treated for sexually transmitted infections. Timed vaginal insemination was performed for up to six menstrual cycles, and a fertility evaluation was offered to couples who did not become pregnant.

Mmeje notes that the method and best practices described in the pilot study could be implemented by HIV prevention programs globally.

"Our findings are applicable to low-resource environments throughout the world," she says. "This strategy could have high impact on empowering HIV-affected women with an affordable and readily accessible reproductive option that supports their desire to have children."


More Articles About:

Lab Report Basic Science and Laboratory Research Wellness and Prevention Health Care Delivery, Policy and Economics HIV and AIDS All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.